Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 30, 2007, Pages 12518-12523

  Steensland, Pia ^a   Simms, Jeffrey A ^a   Holgate, Joan ^a   Richards, Jemma K ^a   Bartlett, Selena E ^a  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

Addiction; Alcohol; Dependence; Nicotine; Treatment

Indexed keywords

ALCOHOL; NALTREXONE; NICOTINIC AGENT; PARTIAL AGONIST; SUCROSE; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG SELECTIVITY; INSTRUMENTAL CONDITIONING; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REBOUND; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME; ADDICTION; ANIMAL; ANIMAL BEHAVIOR; APPETITE; METABOLISM; SENSITIVITY AND SPECIFICITY;

ANIMALIA;

ANIMALS; APPETITE; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; BENZAZEPINES; ETHANOL; MALE; NALTREXONE; NICOTINIC AGONISTS; QUINOXALINES; RATS; RECEPTORS, NICOTINIC; SENSITIVITY AND SPECIFICITY; SUCROSE; WATER;

EID: 34547630911     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0705368104     Document Type: Article

References (57)

1. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson, BA, LoCastro JS, et al. (2006) J Am Med Assoc 295:2003-2017.
2. Altshuler HL, Phillips PE, Feinhandler DA (1980) Life Sci 26:679-688.
3. Froehlich JC, Harts J, Lumeng L, Li TK (1990) Pharmacol Biochem Behav 35:385-390.
4. Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP (2001) Alcohol 23:109-116.
5. Stromberg MF, Volpicelli JR, O'Brien CP (1998) Alcohol Clin Exp Res 22:2186-2191.
6. Volpicelli JR, Davis MA, Olgin JE (1986) Life Sci 38:841-847.
7. Anton RF, Moak DH, Latham PK, Waid LR, Malcolm RJ, Dias JK, Roberts JS (2001) J Clin Psychopharmacol 21:72-77.
8. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Arch Gen Psychiatry 49:881-887.
9. Oslin D, Liberto JG, O'Brien J, Krois S, Norbeck J (1997) Am J Geriatr Psychiatry 5:324-332.
10. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Arch Gen Psychiatry 49:876-880.
11. Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA (2006) J Clin Psychopharmacol 26:610-625.
12. Oslin DW, Berrettini WH, O'Brien CP (2006) Addict Biol 11:397-403.
13. Beczkowska IW, Bowen WD, Bodnar RJ (1992) Brain Res 589:291-301.
14. Stromberg MF, Rukstalis MR, Mackler SA, Volpicelli JR, O'Brien CP (2002) Pharmacol Biochem Behav 72:483-490.
15. Swan GE, Carmelli D, Cardon LR (1997) J Stud Alcohol 58:182-190.
16. Dani JA, Harris RA (2005) Nat Neurosci 8:1465-1470.
17. Davis TJ, de Fiebre CM (2006) Alcohol Res Health 29:179-185.
18. Narahashi T, Aistrup GL, Marszalec W, Nagata K (1999) Neurochem Int 35:131-141.
19. Jones S, Sudweeks S, Yakel JL (1999) Trends Neurosci 22:555-561.
20. Blomqvist O, Ericson M, Johnson DH, Engel JA, Soderpalm B (1996) Eur J Pharmacol 314:257-267.
21. Ericson M, Blomqvist O, Engel JA, Soderpalm B (1998) Eur J Pharmacol 358:189-196.
22. Le AD, Corrigall WA, Harding JW, Juzytsch W, Li TK (2000) Alcohol Clin Exp Res 24:155-163.
23. Blomqvist O, Ericson M, Engel JA, Soderpalm B (1997) Eur J Pharmacol 334:149-156.
24. Tizabi Y, Copeland RL, Jr, Louis VA, Taylor RE (2002) Alcohol Clin Exp Res 26:394-399.
25. Blomqvist O, Hernandez-Avila CA, Van Kirk J, Rose JE, Kranzler HR (2002) Alcohol Clin Exp Res 26:326-331.
26. Chi H, de Wit H (2003) Alcohol Clin Exp Res 27:780-786.
27. Young EM, Mahler S, Chi H, de Wit H (2005) Alcohol Clin Exp Res 29:58-65.
28. Larsson A, Edstrom L, Svensson L, Soderpalm B, Engel JA (2005) Alcohol Alcohol 40:349-358.
29. Rada P, Johnson DF, Lewis MJ, Hoebel BG (2004) Pharmacol Biochem Behav 79:599-605.
30. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ (1992) Mol Pharmacol 41:31-37.
31. Zoli M, Lena C, Picciotto MR, Changeux JP (1998) J Neurosci 18:4461-4472.
32. Aistrup GL, Marszalec W, Narahashi T (1999) Mol Pharmacol 55:39-49.
33. Cardoso RA, Brozowski SJ, Chavez-Noriega LE, Harpold M, Valenzuela CF, Harris RA (1999) J Pharmacol Exp Ther 289:774-780.
34. Moriguchi S, Zhao X, Marszalec W, Yeh JZ, Narahashi T (2007) Alcohol Clin Exp Res 31:89-99.
35. Tritto T, Marley RJ, Bastidas D, Stitzel JA, Collins AC (2001) Alcohol 24:69-78.
36. Butt CM, King NM, Stitzel JA, Collins AC (2004) J Pharmacol Exp Ther 308:591-599.
37. Owens JC, Balogh SA, McClure-Begley TD, Butt CM, Labarca C, Lester HA, Picciotto MR, Wehner JM, Collins AC (2003) Alcohol Clin Exp Res 27:1867-1875.
38. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, et al. (2005) J Med Chem 48:3474-3477.
39. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, et al. (2007) Neuropharmacology 52:985-994.
40. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR (2006) J Am Med Assoc 296:47-55.
41. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR (2006) J Am Med Assoc 296:56-63.
42. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR (2006) J Am Med Assoc 296:64-71.
43. Wise RA (1973) Psychopharmacologia 29:203-210.
44. Mihalak KB, Carroll FI, Luetje CW (2006) Mol Pharmacol 70:801-805.
45. Larsson A, Svensson L, Soderpalm B, Engel JA (2002) Alcohol 28:157-167.
46. Ericson M, Molander A, Lof E, Engel JA, Soderpalm B (2003) Eur J Pharmacol 467:85-93.
47. Yoshida K, Engel J, Liljequist S (1982) Naunyn Schmiedebergs Arch Pharmacol 321:74-76.
48. Dohrman DP, Reiter CK (2003) Brain Res 975:90-98.
49. Jerlhag E, Grotli M, Luthman K, Svensson L, Engel JA (2006) Alcohol Alcohol 41:486-493.
50. Rezvani AH, Overstreet DH, Yang Y, Maisonneuve IM, Bandarage UK, Kuehne ME, Glick SD (1997) Pharmacol Biochem Behav 58:615-619.
51. Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, Coe JW (2006) Drug Metab Dispos 34:121-130.
52. Williams KE, Reeves KR, Billing CB, Jr, Pennington AM, Gong J (2007) Curr Med Res Opin 23:793-801.
53. Samson HH (1986) Alcohol Clin Exp Res 10:436-442.
54. Ciccocioppo R, Lin D, Martin-Fardon R, Weiss F (2003) Psychopharmacology 168:208-215.
55. Perfumi M, Santoni M, Cippitelli A, Ciccocioppo R, Froldi R, Massi M (2003) Alcohol Clin Exp Res 27:1554-1562.
56. Committee on Care and Use of Laboratory Animals (1985) Guide for the Care and Use of Laboratory Animals (Natl Inst Health, Bethesda), DHHS Publ No (NIH) 85-23.
57. Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE (2007) Trends Pharmacol Sci 10.1016/Jtips.2007.05.003.